These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 146766)

  • 1. Deficient cell-mediated immunity in head and neck cancer patients secondary to autologous suppressive immune cells.
    Berlinger NT; Hilal EY; Oettgen HF; Good RA
    Laryngoscope; 1978 Mar; 88(3):470-83. PubMed ID: 146766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal dinitrochlorobenzene skin sensitization: a prognostic sign of survival in head and neck squamous cell carcinoma.
    Maisel RH; Ogura JH
    Laryngoscope; 1973 Dec; 83(12):2012-9. PubMed ID: 4772104
    [No Abstract]   [Full Text] [Related]  

  • 3. [The value of CEA in post-therapeutic monitoring of head and neck carcinoma].
    Fiorella R; Di Nicola V; Giannubilo C; Facondo M
    Acta Otorhinolaryngol Ital; 1988; 8(2):133-6. PubMed ID: 3188902
    [No Abstract]   [Full Text] [Related]  

  • 4. A search for common tumor specific antigen and serum blocking factor in head and neck epidermoid carcinomas.
    Kennedy JT
    Laryngoscope; 1975 May; 85(5):806-22. PubMed ID: 49834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cellular immune defect caused by postoperative irradiation in patients with squamous epithelial carcinomas of the upper aerodigestive tract].
    Maier H; Daniel V; Heimlich F; Frank C; Opelz G
    HNO; 1995 Jun; 43(6):364-70. PubMed ID: 7642397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukocyte antigen class I expression on squamous cell carcinoma cells regulates natural killer cell activity.
    Lutz CT; Kurago ZB
    Cancer Res; 1999 Nov; 59(22):5793-9. PubMed ID: 10582701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immune functions in cancers of the upper respiratory and digestive tracts].
    Follézou JY; Bayssas M; Provost MA; Fridman WH; Dumont J; Point D; Brugère J
    Nouv Presse Med; 1978 Oct; 7(37):3368. PubMed ID: 733515
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunity indices of patients with locally disseminated malignant neoplasms of the head and neck].
    Bulbuk GA
    Vopr Onkol; 1982; 28(4):57-9. PubMed ID: 7090271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulating effects of surgical intervention in tumors of the head and neck.
    Dietz A; Heimlich F; Daniel V; Polarz H; Weidauer H; Maier H
    Otolaryngol Head Neck Surg; 2000 Jul; 123(1 Pt 1):132-9. PubMed ID: 10889496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of thymosin and irradiation on immune modulation in head and neck and esophageal cancer patients.
    Wara WM; Ammann AJ; Wara DW
    Cancer Treat Rep; 1978 Nov; 62(11):1775-8. PubMed ID: 728896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased sensitivity of T lymphocytes to normal adherent suppressor cells in patients with head and neck cancer.
    Pierri I; Cordone G; Rogna S; Pende D; Garaventa G; Barabino A; Indiveri F
    Cancer Detect Prev; 1984; 7(2):73-8. PubMed ID: 6231991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transference of cell mediated immunity in patients with head and neck cancer.
    Vetto RM; Burger DR
    Laryngoscope; 1978 Jan; 88(1 Pt 2 Suppl 8):79-82. PubMed ID: 304143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and localization of tumor-associated immune components of head and neck squamous cell carcinomas.
    Popović D; Gill L; Sisson G; Applebaum E; Anderson B
    Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol; 1976; 82(2):119-30. PubMed ID: 59450
    [No Abstract]   [Full Text] [Related]  

  • 14. Levamisole versus placebo as an adjunct to primary therapy of laryngopharyngeal epidermoid carcinoma. Evaluation of the immune status.
    Mussche RA; Plum J; de Smedt M; Kluyskens P
    Acta Otorhinolaryngol Belg; 1977; 31(6):566-77. PubMed ID: 339662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunglobulins in serum of laryngeal and pharyngeal cancer patients (author's transl)].
    Niksić M; Balogh M
    Laryngol Rhinol Otol (Stuttg); 1976 Nov; 55(11):882-7. PubMed ID: 136570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of cell-mediated effector mechanisms in lung cancer.
    Feo Figarella E; Morillo F; Blanca I; Bianco NE
    J Natl Cancer Inst; 1984 Jul; 73(1):1-6. PubMed ID: 6330420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression of the generation of cell-mediated cytotoxicity by macrophage-like suppressor cells in bladder carcinoma patients.
    Spina CA; Dorey F; Vescera C; Brosman S; Fahey JL
    Cancer Res; 1981 Nov; 41(11 Pt 1):4324-30. PubMed ID: 6458353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphokine production and lymphocyte subpopulations in patients with head and neck squamous carcinoma.
    Wolf GT; Lovett EJ; Peterson KA; Beauchamp ML; Baker SR
    Arch Otolaryngol; 1984 Nov; 110(11):731-5. PubMed ID: 6237633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cell-mediated immunity in oral cancer patients.
    Rao RS; Fakih AR; Nair CN; Gangal SG; Naik SL
    Indian J Cancer; 1984 Nov-1985 Jan; 21(5-6):141-5. PubMed ID: 6336234
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppression of T-cell response in autologous mixed lymphocyte-tumor culture by large granular lymphocytes.
    Uchida A; Klein E
    J Natl Cancer Inst; 1986 Mar; 76(3):389-98. PubMed ID: 2419621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.